Clinical trials
Phase 3 Multiple Sclerosis trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Apurano Pharmaceuticals GmbH | 2 |
| MedDay Pharmaceuticals SA | 2 |
| Apimeds, Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Central Texas Neurology Consultants | 1 |
| Glostrup University Hospital, Copenhagen | 1 |
| Hospices Civils de Lyon | 1 |
| Hospital San Carlos, Madrid | 1 |
| Karolinska Institutet | 1 |
| Mazandaran University of Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 19 |
| Optic Neuritis | 3 |
| Pain | 3 |
| Agnosia | 2 |
| Brain Injuries, Traumatic | 2 |
| Chronic Pain | 2 |
| Marijuana Abuse | 2 |
| Multiple Sclerosis, Chronic Progressive | 2 |
| Multiple Sclerosis, Relapsing-Remitting | 2 |
| Neuralgia | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.